164 related articles for article (PubMed ID: 34484467)
1. ANGPTL3 Overexpression Suppresses the Development of Oncogenic Properties in Renal Cell Carcinoma via the Wnt/
Zhang YJ; Zhang L; Feng F; Cao QF
Dis Markers; 2021; 2021():2863856. PubMed ID: 34484467
[TBL] [Abstract][Full Text] [Related]
2. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
[TBL] [Abstract][Full Text] [Related]
3. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
Zhao W; Yang S; Chen J; Zhao J; Dong J
Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
[TBL] [Abstract][Full Text] [Related]
4. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NBAT1 suppresses cell proliferation and migration via miR-346/GSK-3β axis in renal carcinoma.
Xue S; Wang S; Li J; Guan H; Jiang S; Guo Y; Li Q
IUBMB Life; 2019 Nov; 71(11):1720-1728. PubMed ID: 31298469
[TBL] [Abstract][Full Text] [Related]
6. ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation.
Zhao T; Liang X; Chen J; Bao Y; Wang A; Gan X; Lu X; Wang L
Biochem Biophys Res Commun; 2019 Aug; 516(3):880-887. PubMed ID: 31270029
[TBL] [Abstract][Full Text] [Related]
7. WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.
Hsu RJ; Ho JY; Cha TL; Yu DS; Wu CL; Huang WP; Chu P; Chen YH; Chen JT; Yu CP
PLoS One; 2012; 7(10):e47649. PubMed ID: 23094073
[TBL] [Abstract][Full Text] [Related]
8. BMX activates Wnt/β-catenin signaling pathway to promote cell proliferation and migration in breast cancer.
Li K; Pan WT; Ma YB; Xu XL; Gao Y; He YQ; Wei L; Zhang JW
Breast Cancer; 2020 May; 27(3):363-371. PubMed ID: 31728872
[TBL] [Abstract][Full Text] [Related]
9. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SUMO1P3 regulates the invasion, migration and cell cycle of gastric cancer cells through Wnt/β-catenin signaling pathway.
Xu Z; Ran J; Gong K; Hou Y; Li J; Guo Y
J Recept Signal Transduct Res; 2021 Dec; 41(6):574-581. PubMed ID: 33179980
[TBL] [Abstract][Full Text] [Related]
11. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
[TBL] [Abstract][Full Text] [Related]
12. LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.
Ma B; Zhang J; Zhou W; Chu C; Zhao C; Zhang Z; Huang T
Biochem Biophys Res Commun; 2018 Oct; 505(1):7-12. PubMed ID: 30224058
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH
Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469
[TBL] [Abstract][Full Text] [Related]
14. Reduced E-cadherin facilitates renal cell carcinoma progression by WNT/β-catenin signaling activation.
Zhang X; Yang M; Shi H; Hu J; Wang Y; Sun Z; Xu S
Oncotarget; 2017 Mar; 8(12):19566-19576. PubMed ID: 28223537
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA ENST00000434223 inhibits the progression of renal cancer through Wnt/hygro-catenin signaling pathway.
Luo NQ; Ma DR; Yang XC; Liu Y; Zhou P; Guo LJ; Huang XD
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6868-6877. PubMed ID: 31486486
[TBL] [Abstract][Full Text] [Related]
16. MiR-200c/FUT4 axis prevents the proliferation of colon cancer cells by downregulating the Wnt/β-catenin pathway.
Cong J; Gong J; Yang C; Xia Z; Zhang H
BMC Cancer; 2021 Jan; 21(1):2. PubMed ID: 33397320
[TBL] [Abstract][Full Text] [Related]
17. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
18. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]